Anlon Healthcare

Anlon Healthcare

Mainboard

₹14,924 / 164 Shares

Offer Date:Aug 26, 2025 - Aug 29, 2025

IPO Live Subscription Details (times)

Date:29 Aug 2025,06:45:00 PM
QIBs:1.07
NII:Bids above ₹10L: 7.56x
Bids below ₹10L: 16.69x
NII Total: 10.61
Retail:47.30x
Total:7.13 times

IPO Details

Anlon Healthcare IPO is priced between ₹86-91 per equity share, with a face value of ₹10 per share. The company's equity shares will be listed on the Mainboard, and Kfin Technologies Ltd is managing the issue as the registrar.

The IPO bidding period opened on 26 Aug, 2025, and closed on 29 Aug, 2025. The allotment results will be announced on 1 Sep, 2025, with a tentative listing date set for 3 Sep, 2025.

The total issue comprises 1,33,00,000 shares, amounting to ₹121.03 Cr.

Anlon Healthcare IPO Highlights

IPO DateListing DateFace ValuePrice BandLot SizeFresh IssueOffer for SaleListing At
Aug 26, 2025 - Aug 29, 20253 Sep, 2025₹10 Per Equity Share₹86-91 per equity share164 Shares Shares -BSE, NSE

Anlon Healthcare IPO Timeline

IPO Open Date
26 Aug, 2025
IPO Close Date
29 Aug, 2025
Basis of Allotment
1 Sep, 2025
Listing Date
3 Sep, 2025

Issue Price

₹86-91 per equity share

Face Value

₹10 Per Equity Share

Listing at Group

BSE, NSE

Registrar

Kfin Technologies Ltd

Market Lot

Retail: 164 Shares (₹14,924/-)
S-HNI: 2,296 Shares (₹2,08,936/-)
B-HNI: 11,152 Shares (₹10,14,832/-)

Lead Manager

Interactive Financial Services Ltd

Issue Size

1,33,00,000 shares(aggregating up to ₹121.03 Cr)

Retail Portion

10% (Number of Retail Applications: 8,110 Approx),(Number of S-HNI Applications : 290 Approx),(Number of B-HNI Applications : 579 Approx)

Subscription

7.10 times

IPO Docs

DRHP RHP

Anlon Healthcare IPO Financial Information

Period EndedAssetsRevenueProfit After TaxNet WorthReserves and SurplusTotal Borrowing
31 Mar 25181.30120.4620.5280.4240.5758.35
31 Mar 24128.0066.699.6621.035.0374.56
31 Mar 23111.55113.125.827.37-4.6366.39

All values are in ₹ Cr.

Anlon Healthcare IPO Valuations

EPS PRE IPO

₹5.15/-

EPS POST IPO

₹3.86/-

PE PRE IPO

17.67

PE POST IPO

23.57

ROE

40.45%

ROCE

21.93%

DEBT EQUITY

0.73

RONW

25.51%

PAT MARGIN

17.06%

PRICE TO BOOK VALUE

4.51

About Company

Anlon Healthcare Limited was incorporated in 2013. It is a chemical manufacturing firm involved in the production of Pharma Intermediates and active pharmaceutical ingredients (APIs).

The firm produces high-purity pharmaceutical intermediates (for API synthesis) and active pharmaceutical ingredients (utilized in formulations for pharmaceuticals, nutraceuticals, personal care, and animal health products).The firm deals in pharma intermediates, APIs for drugs, nutraceuticals, personal care, and veterinary products, all of which are produced to Indian and international pharmacopeia standards such as IP, BP, EP, JP, and USP.Besides producing Pharma Intermediates and APIs to international specifications, the firm now provides contract manufacturing of complex chemicals beyond purity levels and lowering impurities to suit particular customers' requirements.

The firm has been approved by ANVISA, NMPA, and PMDA for loxoprofen sodium dihydrate and loxoprofen acid APIs in terms of Drug Master File (DMF). The firm has submitted 21 DMFs to worldwide authorities and is submitting for Ketoprofen and Dexketoprofen Trometamol approvals.65 commercial products, 28 pilot-scale products, and 49 lab-scale products are part of the firm's portfolio.

The firm maintains product quality through thorough testing, analysis, and process optimization. Backed by four laboratories, the 34-strong team, which comprises 24 science graduates, guarantees that products meet customer and industry requirements.

Read More

Anlon Healthcare IPO Subscription Details

As onQIBNII
bNII  sNII
RetailTotal
Shares Offered / Reserved99,75,000
19,95,000

13,30,000    6,65,000
13,30,0001,33,00,000
Day 1 - 26-08-25 05:00 PM0.91 x
0.71

0.48 x   1.17 x
8.99 x1.69 x
Day 2 - 28-08-25 05:00 PM1.01 x
2.09

1.38 x   3.51 x
22.32 x3.30 x
Day 3 - 28-08-25 05:00 PM1.07 x
10.60

7.56 x   16.66 x
47.04 x7.10 x
Total No. of Applications:3,34,665 (Approx)
Retail Subscription:

Retail:42.0x

BHNI:1.5x

SHNI:16.0x times

Anlon Healthcare IPO - Issue Objectives

  1. Funding capital expenditure requirements for Proposed Expansion
  2. Full or part repayment and/or prepayment of certain outstanding secured borrowingssecured borrowing (term loan)availed by the Company
  3. Funding the working capital requirements of the Company
  4. General corporate purposes
Company Contact Details

Anlon Healthcare

101/102, Silvercoin Complex, Opp.Crystal Mall,Kalawad Road Rajkot, Gujarat, 360005

Phone: +91 281 2562538

Email: cs@anloncro.com

Website: http://www.anlon.in/

Registrar Contact Details

Kfin Technologies Limited

Phone: 04067162222, 04079611000

Email: ahl.ipo@kfintech.com

Website: https://kosmic.kfintech.com/ipostatus/